HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

Nick Dand; Michael Duckworth; David Baudry; Alice Russell; Charles Curtis; Sang Hyuck Lee; Ian M. Evans; K.J. Mason; Ali Alsharqi; G Becher; A. David Burden; Richard G. Goodwin; Kevin E. McKenna; Ruth Murphy; Gayathri Perera; Radu Rotarescu; Shyamal Wahie; Andrew Wright; Nick J. Reynolds; Richard B. Warren; Christopher Em Griffiths; Catherine Smith; Michael A. Simpson; Juliet N. Barker; Marilyn Benham; Sagair Hussain; Brian Kirby; Linda Lawson; Kathleen McElhone; Anthony D. Ormerod; Caroline Owen; Michael R. Barnes; Paola Di Meglio; Richard Emsley; Andrea Evans; Katherine Payne; Deborah Stocken

doi:10.1016/j.jaci.2018.11.038

Related publications

Article2021

Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis

Konstantinos Douroudis, Ravi Ramessur, Inês A. Barbosa, David Baudry, Michael Duckworth, Caroline Angit, Francesca Capon, Raymond T. Chung, Charles Curtis, Paola Di Meglio, J. M. R. Goulding, Christopher Em Griffiths, Sang Hyuck Lee, Richard Parslew, Nick J. Reynolds, Alexa R. Shipman, Richard B. Warren, Zenas Z N Yiu, Michael A. Simpson, Juliet N. Barker, Nick Dand, Catherine Smith, Ian M. Evans, Ruth Murphy, Tess McPherson, Elise Kleyn, Philip Laws, G Becher, Anthony Bewley, Amir Rashid, Oras Alabas, Simon Morrison, Shehnaz Ahmed, Eleanor Pearson, Josh Richards, Teena Mackenzie, Brian Kirby, David Burden, Linda Lawson, Kathleen McElhone, Anthony D. Ormerod, Caroline Owen, Nadia Aldoori, Mahmud Ali, Alex Anstey, Fiona Antony, Charles W. Archer, Suzanna August, Periasamy Balasubramaniam, Kay Baxter, Anthony Bewley, Alexandra Bonsall, Victoria Brown, Katya Burova, Aamir Butt, S. Cliff, Mihaela Costache, S. Darné, Emily Davies, Claudia DeGiovanni, Trupti Desai, Bernadette DeSilva, Victoria Diba, Eva Domanne, Harvey Dymond, Caoimhe Fahy, Leila Ferguson, Maria‐Angeliki Gkini, Alison Godwin, Fiona Hammonds, Sarah M. Johnson, Teresa Joseph, Manju Kalavala, Mohsen Khorshid, Liberta Labinoti, Nicole Lawson, Alison Layton, Tara Lees, N. J. Levell, Helen M. Lewis, Calum C. Lyon, Sandy McBride, Sally McCormack, Kevin E. McKenna, Serap Mellor, Ruth Murphy, P.G. NORRIS, Caroline Owen, Urvi Popli, Gay Perera, Nabil Ponnambath, Helen Ramsay, Aruni Ranasinghe, Saskia Reeken, Rebecca Rose, Rada Rotarescu, Ingrid Salvary, Kathy Sands

Article2018

A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis

Amy Foulkes, David Watson, Daniel F. Carr, John Kenny, Timothy Slidel, Richard Parslew, Munir Pirmohamed, Simon Anders, Nick J. Reynolds, Christopher Em Griffiths, Richard B. Warren, Michael R. Barnes

Article2007

Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis

Pauline Ho, Anne Barton, Jane Worthington, Darren Plant, Christopher Em Griffiths, Helen Young, Peter Bradburn, Wendy Thomson, Alan J. Silman, Ian N Bruce

Article2019

PSS6 COMPARISON OF TREATMENT SWITCHING AMONG BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGIC TREATMENT: RESULTS FROM A US CLAIMS DATABASE

David Kaplan, Benjamin S.‐Y. Ung, Corey Pelletier, Chuka Udeze, M. Tian

Article2021

Defining trajectories of response in patients with psoriasis treated with biologic therapies

Nophar Geifman, Narges Azadbakht, J. Zeng, Tom Wilkinson, Nick Dand, Iain Buchan, Deborah Stocken, P. Di Meglio, Richard B. Warren, Juliet N. Barker, NJ Reynolds, Michael R. Barnes, Catherine Smith, Christopher Em Griffiths, Niels Peek